Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile

2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile is listed in the pharmaceutical impurity collection under CAS 1416243-47-4. Its represented structure has formula C15H14FN3 and a calculated molecular weight of 255.30 g/mol.

2D chemical structure

N F N H N

Chemical identity

Catalog name
2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile
Common name
2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile
Chemical name
4-(6,6-dimethyl-4,5-dihydro-1H-cyclopenta[d]pyrazol-4-yl)-2-fluorobenzonitrile
CAS
1416243-47-4
SMILES
CC1(C)CC(c2ccc(C#N)c(F)c2)c2cn[nH]c21
InChI
InChI=1S/C15H14FN3/c1-15(2)6-11(12-8-18-19-14(12)15)9-3-4-10(7-17)13(16)5-9/h3-5,8,11H,6H2,1-2H3,(H,18,19)
InChIKey
PNYKKTIKOQKRHR-UHFFFAOYSA-N

Record ID: Aa209a7ce5fb1

Computed properties

C15H14FN3 Molecular formula
255.296 g/molMolecular weight
255.1172 DaMonoisotopic exact mass
52.47 ŲTopological polar surface area
3.2337 Calculated LogP (Wildman–Crippen)
69.1887 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N 0 4 8 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight255.29631.43
Calculated LogP (Wildman–Crippen)3.233766.09
Topological polar surface area52.4733.38
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC15H14FN3dimensionless
Molecular weight255.296g/mol
Monoisotopic exact mass255.1172Da
Topological polar surface area52.47Ų
Calculated LogP (Wildman–Crippen)3.2337dimensionless
Molar refractivity (Wildman–Crippen)69.1887cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)1count
Heavy atoms19count
Heteroatoms4count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.3333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area110.6277Ų
Valence electrons96count
Radical electrons0count
Bertz complexity678.9394index
Balaban J2.064index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile

Qualification and safety assessment of 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile

Explore toxicological qualification of 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile and ICH M7 mutagenic impurity assessment of 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile and acceptable intake and limit justification for 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 2-Fluoro-4-(1,4,5,6-tetrahydro-6,6-dimethyl-4-cyclopentapyrazolyl)benzonitrile

Explore Altox services and software through the Altox Pharma-Hub.